Alpha-1 antitrypsin deficiency (A1AD or AATD) is a genetic disorder that may result in lung disease or liver disease. Onset of lung problems is typically between 20 and 50 years old. This may result in shortness of breath, wheezing, or an increased risk of lung infections. Design and create a respiratory care plan for a patient with Alpha 1 antitrypsin deficiency. Include in a critical review to include signs and symptoms, causes, epidemiological data, related disorders, diagnosis, treatment modalities, and respiratory manifestations.
